High-in-demand health supplements bolster Holista Colltech’s (ASX:HCT) sales growth in ~US$360B market

Highlights

• Holista Colltech is one of the leading innovators in health and wellness solutions.
• The company’s Dietary Supplements division has been the biggest contributor to its total revenue in recent quarters.
• Future growth will be bolstered by launch of new product innovations.
• Global supplements market is estimated to be worth ~US$360bn and growing at a 6.3% CAGR from 2022 to 2030, according to Grand View Research .
• Holista offers its customers 37 varieties of propriety supplements and owns a number of market leading brands.

Renowned research-driven biotech company Holista Colltech Limited (ASX:HCT) is an innovator in health and wellness solutions. The company hosts four core business divisions - Dietary Supplements, Healthy Food Ingredients, Ovine Collagen, and Infection Control Solutions. In today’s article, we will elaborate on its largest division of health supplements that helps people live healthier lives.

Over the years, the company has successfully developed and patented world-leading technologies catering to the global health & wellness Industry.  

The ASX-listed company is fast gaining popularity among masses for offering health-related solutions with a blend of nature and science. Its key products include a suite of market-leading and best-selling health supplements.

ALSO READ: Holista’s all-natural disinfectant kills 99.99% of human coronavirus strain, confirms test

Flourishing market for Holista’s health supplements

After the COVID-19 pandemic, people have become more health conscious. The change made Holista’s Health Supplements Division the biggest contributor to its total sales growth in the recent quarters.

The vitamin and health supplement brands under the division have emerged as one of the market leaders in Malaysia. There was a surge of 31% year-on-year to AU$1.9 million in the sales of Holista’s market-leading supplements and vitamins in March 2022 quarter.

Further, global demand for supplements is increasing. The market for nutritional supplements is estimated to be worth US$358.8 billion in 2021 and is forecast to grow at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030, according to Grand View Research.

ALSO READ: Holista Colltech scores big, signs initial order for Starbucks and Country Farms

The secret of the high-in-demand health supplements

Holista offers total 37 varieties of propriety supplements through its two wholly owned subsidiaries. One of the main constituents of the products is Pristin® MOPL™ which contains third-generation Omega-3 sourced from herring caviar harvested by Arctic Nutrition in Norway. Its unique phospholipids structure makes it both fat as well as water-soluble.

It has been clinically proven that Pristin® MOPL™ has high absorption rate of nutrients as compared to other products available in the market.

Omega-3 phospholipids have more than double the absorption rate of fish oils typically sourced from salmon or krill. It can boost cognitive performance and overall health of the heart, liver, kidneys, lungs, and skin.

Moreover, the company delivers first-class natural ingredients and wellness products.

New range of products in June quarter

The ASX-listed company is forging ahead with the goal to develop natural health supplements and consumer products for its customers that are scientifically enhanced, engineered and tested.

Holista recently launched its water-soluble vitamin D innovation. With further plans to elevate sales of its Health Supplements division, Holista is looking forward to launching new products, such as a natural sugar and starch blocker, called In2Bloc, in the current quarter.

Stock information: HCT shares last traded at AU$0.029 on 25 May 2022, with market capitalisation of AU$7.98 million.

Do read: What’s behind Holista Colltech’s (ASX:HCT) bullish FY22 outlook in this volatile market?